Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05747443 · ClinicalTrials.gov registry record · NA
Multilevel Interventions to Increase Adherence to Lung Cancer Screening
A NA study of Lung Cancer and Lung Cancer Screening, sponsored by Kaiser Permanente.
- Active
- Registry status
- NA
- Development phase
- 1,837
- Enrollment target
- 1
- Study location
NCT05747443: Active NA study of Lung Cancer and Lung Cancer Screening, sponsored by Kaiser Permanente.
NCT05747443 is a NA study of Lung Cancer and Lung Cancer Screening that is active but no longer recruiting, run by Kaiser Permanente. The registered enrollment target is 1,837 participants, above the 931-participant average among 409 other Lung Cancer trials with a reported enrollment target (97% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05747443, a NA study of Lung Cancer and Lung Cancer Screening, is active but no longer recruiting, sponsored by Kaiser Permanente.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,837 participants
- Enrollment target
- 1
- Study location
Study Summary
Screening for lung cancer has the potential for a profound public health benefit. Repeat annual screening is necessary for early detection of lung cancer. The investigators will test two interventions which include patient education and reminders to improve adherence to lung cancer screening.
Primary Outcome
Electronic health records will be searched for screening low dose CT (LDCT).
Conditions Studied
Interventions
- OTHER Patient Education
- OTHER Stepped Reminders
Study Locations (1)
Washington
- Kaiser Permanente - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,837 participants |
| Start Date | 2022-12-12 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What the registry record for NCT05747443 still lists
NCT05747443 is an interventional study that assigns participants to a tested intervention. Its 1,837 participants enrollment target places it among the larger protocols in the corpus, above the 931-participant average among 409 other Lung Cancer trials with a reported enrollment target (97% higher).
The record links to 2 conditions, with Lung Cancer appearing as the primary indexed condition, and to 2 interventions - of which Patient Education is the first listed.
NCT05747443 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT05747443 about?
NCT05747443 is a clinical study titled "Multilevel Interventions to Increase Adherence to Lung Cancer Screening". Screening for lung cancer has the potential for a profound public health benefit. Repeat annual screening is necessary for early detection of lung cancer. The investigators will test two interventions which include patient education and reminders to improve adherence to lung cancer screening.
What is the current status of trial NCT05747443?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,837 participants. The study started on 2022-12-12. Estimated completion is 2026-06-30.
What conditions does trial NCT05747443 study?
This clinical trial studies the following conditions: Lung Cancer, Lung Cancer Screening.
What interventions are being tested in trial NCT05747443?
The interventions under investigation include: Patient Education (OTHER), Stepped Reminders (OTHER).
Who is sponsoring clinical trial NCT05747443?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05747443 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05747443's enrollment target sits among peer trials
1,837 31st of 409 higher than 379 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
RECRUITING · NA
-
Exercise as Maintenance Therapy in Advanced Lung Cancer
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07104240 · 1,836 participants · NA
A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax Trial
- NCT06740630 · 1,840 participants · Phase 3
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
- NCT06465810 · 1,850 participants
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- NCT06580080 · 1,850 participants · NA
Evaluation of Are You Ready?
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI